NCT06879431

Brief Summary

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered school-aged children undergoing congenital heart surgery. The study will include infants and toddlers undergoing elective cardiac surgery with sleep disorders, assessed by the Children's Sleep Habits Questionnaire (CSHQ). All participants will be randomly assigned to the intervention group and Controll group in a 1:1 ratio. The intervention group received a short intensive cognitive-behavioral intervention 7-14 days before surgery, and no intervention was imposed on the control group. The results of this study will provide suggestions for the prevention of delirium after cardiac surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
544

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Apr 2025Dec 2026

First Submitted

Initial submission to the registry

February 25, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 17, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

April 28, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

May 31, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

February 25, 2025

Last Update Submit

May 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of postoperative delirium

    Postoperative 7 days

Secondary Outcomes (20)

  • Mechanistic endpoint: Concentration of plasma S-100β protein

    Before surgery, at the end of surgery and 24 hours after surgery

  • Pain defined by the Wong-Baker faces pain scale (revision)

    Postoperative 7 days

  • The incidence of postoperative Acute kidney injury

    Within postoperative 7 days

  • The incidence of Pulmonary complication

    Postoperative 7 days

  • The incidence of postoperative Liver dysfunction

    Postoperative 7 days

  • +15 more secondary outcomes

Other Outcomes (4)

  • Long-term Sleep quality score

    30 days, six months, 1 year postoperatively

  • Strengths and Difficulties Questionnaire Score

    6 months and 1 year after surgery

  • Readmission rate

    30 days,6 months,1 year after discharge

  • +1 more other outcomes

Study Arms (2)

CBT group

EXPERIMENTAL

The intervention group received a short intensive cognitive-behavioral therapy (CBT) intervention 7-14 days before surgery

Behavioral: cognitive-behavioral intervention

control group

NO INTERVENTION

no intervention was imposed on the control group

Interventions

After enrollment in the experimental group, the guardians were asked to fill out a sleep diary every day before surgery to self-report the children's sleep, and to wear a somatic movement recorder to monitor sleep (non-dominant arm) (wGT3x-BT accelerometer, ActiGraph) during the preoperative hospitalization period, except during surgery, and then to wear it to record the sleep-related parameters until 7 days after surgery or before discharge from the hospital.Preoperative daily cognitive-behavioral interventions (developmental trials were guided with WeChat applets), including cognitive change, sleep hygiene, sleep restriction, stimulus control, and relaxation training

CBT group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 0-36 months
  • Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.
  • Sleep disorder assessed by Children's Sleep Habits Questionnaire (CSHQ) (CSHQ score \>48)

You may not qualify if:

  • Preoperative use of sleep therapy-related medications
  • The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4
  • History of preoperative cardiac assist device, mechanical ventilation support, or asphyxia rescue
  • Emergency surgery or preoperative ICU admission
  • History of neurodevelopmental disorders such as autism spectrum disorder, attention deficit hyperactivity disorder, or psychiatric disorders such as depression
  • Combined severe hepatic and renal dysfunction
  • Combination of non-cardiac malformations (adenoid hypertrophy, tracheobronchial stenosis, polysplenism, anaplastic syndrome, Down syndrome, DiGeoge syndrome, diabetes mellitus, reproductive system abnormalities, anal atresia and Williams syndrome, eye disorders)
  • History of preoperative cerebral ischemia and hypoxia
  • Concurrent participation in other clinical trials
  • Refusal of the family to sign the informed consent form or poor compliance by the child

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital, Chinese Academy of Medical Sciences

Beijing, 100037, China

RECRUITING

MeSH Terms

Conditions

Emergence DeliriumParasomniasHeart Defects, Congenital

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersSleep Wake DisordersCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Fuxia Yan

    Chinese Academy of Medical Sciences, Fuwai Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 17, 2025

Study Start

April 28, 2025

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

May 31, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations